Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa Induced Dyskinesias (LID)”

14 trials

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT02202551
What this trial is testing

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 223
Large-scale testing (Phase 3)Ended earlyNCT02153645
What this trial is testing

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesias (LID)
Adamas Pharmaceuticals, Inc. 87
Not applicableActive Not RecruitingNCT02347254
What this trial is testing

ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
InSightec 6
Large-scale testing (Phase 3)WithdrawnNCT03987750
What this trial is testing

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Zambon SpA
Testing effectiveness (Phase 2)Study completedNCT03162874
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

Who this might be right for
Parkinson Disease
Prexton Therapeutics 157
Large-scale testing (Phase 3)Study completedNCT02136914
What this trial is testing

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease
Adamas Pharmaceuticals, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Testing effectiveness (Phase 2)WithdrawnNCT03331848
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)

Who this might be right for
Parkinson Disease
Prexton Therapeutics
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Not applicableWithdrawnNCT01003002
What this trial is testing

Natural History of Levodopa-Induced Dyskinesia (LID)

Who this might be right for
Parkinson's Disease
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT03531060
What this trial is testing

A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 15
Large-scale testing (Phase 3)Ended earlyNCT02153632
What this trial is testing

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Adamas Pharmaceuticals, Inc. 135
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT02439203
What this trial is testing

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Bukwang Pharmaceutical 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation